Lyell Immunopharma Statistics
 Total Valuation
 LYEL has a market cap or net worth of $320.06 million. The enterprise value is $78.32 million.
 Important Dates
 The next estimated earnings date is Wednesday, November 12, 2025, after market close.
 | Earnings Date | Nov 12, 2025 | 
| Ex-Dividend Date | n/a | 
Share Statistics
 LYEL has 19.21 million shares outstanding. The number of shares has increased by 11.19% in one year.
 | Current Share Class | 19.21M | 
| Shares Outstanding | 19.21M | 
| Shares Change (YoY) | +11.19% | 
| Shares Change (QoQ) | +0.26% | 
| Owned by Insiders (%) | 2.60% | 
| Owned by Institutions (%) | 32.33% | 
| Float | 12.05M | 
Valuation Ratios
  | PE Ratio | n/a | 
| Forward PE | n/a | 
| PS Ratio | 5,334.31 | 
| Forward PS | n/a | 
| PB Ratio | 0.83 | 
| P/TBV Ratio | 1.07 | 
| P/FCF Ratio | n/a | 
| P/OCF Ratio | n/a | 
| PEG Ratio | n/a | 
 Financial Ratio HistoryEnterprise Valuation
  | EV / Earnings | n/a | 
| EV / Sales | 1,305.28 | 
| EV / EBITDA | n/a | 
| EV / EBIT | n/a | 
| EV / FCF | n/a | 
Financial Position
 The company has a current ratio of 7.65, with a Debt / Equity ratio of 0.18.
 | Current Ratio | 7.65 | 
| Quick Ratio | 7.50 | 
| Debt / Equity | 0.18 | 
| Debt / EBITDA | n/a | 
| Debt / FCF | n/a | 
| Interest Coverage | n/a | 
Financial Efficiency
 Return on equity (ROE) is -76.59% and return on invested capital (ROIC) is -26.91%.
 | Return on Equity (ROE) | -76.59% | 
| Return on Assets (ROA) | -25.39% | 
| Return on Invested Capital (ROIC) | -26.91% | 
| Return on Capital Employed (ROCE) | -60.58% | 
| Revenue Per Employee | $200 | 
| Profits Per Employee | -$1.10M | 
| Employee Count | 300 | 
| Asset Turnover | 0.00 | 
| Inventory Turnover | n/a | 
Taxes
  | Income Tax | n/a | 
| Effective Tax Rate | n/a | 
Stock Price Statistics
 The stock price has decreased by -1.70% in the last 52 weeks. The beta is -0.08, so LYEL's price volatility has been lower than the market average.
 | Beta (5Y) | -0.08 | 
| 52-Week Price Change | -1.70% | 
| 50-Day Moving Average | 14.71 | 
| 200-Day Moving Average | 11.57 | 
| Relative Strength Index (RSI) | 53.51 | 
| Average Volume (20 Days) | 27,741 | 
Short Selling Information
 The latest short interest is 183,877, so 0.96% of the outstanding shares have been sold short.
 | Short Interest | 183,877 | 
| Short Previous Month | 233,067 | 
| Short % of Shares Out | 0.96% | 
| Short % of Float | 1.53% | 
| Short Ratio (days to cover) | 2.91 | 
Income Statement
 In the last 12 months, LYEL had revenue of $60,000 and -$331.40 million in losses. Loss per share was -$23.52.
 | Revenue | 60,000 | 
| Gross Profit | 60,000 | 
| Operating Income | -211.15M | 
| Pretax Income | -331.40M | 
| Net Income | -331.40M | 
| EBITDA | -194.87M | 
| EBIT | -211.15M | 
| Loss Per Share | -$23.52 | 
 Full Income StatementBalance Sheet
 The company has $276.79 million in cash and $55.11 million in debt, giving a net cash position of $241.74 million or $12.58 per share.
 | Cash & Cash Equivalents | 276.79M | 
| Total Debt | 55.11M | 
| Net Cash | 241.74M | 
| Net Cash Per Share | $12.58 | 
| Equity (Book Value) | 298.92M | 
| Book Value Per Share | 20.16 | 
| Working Capital | 245.31M | 
 Full Balance SheetCash Flow
 In the last 12 months, operating cash flow was -$171.48 million and capital expenditures -$517,000, giving a free cash flow of -$172.00 million.
 | Operating Cash Flow | -171.48M | 
| Capital Expenditures | -517,000 | 
| Free Cash Flow | -172.00M | 
| FCF Per Share | -$8.95 | 
 Full Cash Flow StatementMargins
  | Gross Margin | 100.00% | 
| Operating Margin | -351,916.67% | 
| Pretax Margin | -552,328.33% | 
| Profit Margin | n/a | 
| EBITDA Margin | n/a | 
| EBIT Margin | n/a | 
| FCF Margin | n/a | 
Dividends & Yields
 LYEL does not appear to pay any dividends at this time.
 | Dividend Per Share | n/a | 
| Dividend Yield | n/a | 
| Dividend Growth (YoY) | n/a | 
| Years of Dividend Growth | n/a | 
| Payout Ratio | n/a | 
| Buyback Yield | -11.19% | 
| Shareholder Yield | -11.19% | 
| Earnings Yield | -103.54% | 
| FCF Yield | -53.74% | 
 Analyst Forecast
 The average price target for LYEL is $16.67, which is 0.06% higher than the current price. The consensus rating is "Hold".
 | Price Target | $16.67 | 
| Price Target Difference | 0.06% | 
| Analyst Consensus | Hold | 
| Analyst Count | 3 | 
| Revenue Growth Forecast (5Y) | 342.10% | 
| EPS Growth Forecast (5Y) | n/a | 
 Stock ForecastsFair Value
 There are several formulas that can be used to estimate the intrinsic value of a stock.
 | Lynch Fair Value | n/a | 
| Lynch Upside | n/a | 
| Graham Number | n/a | 
| Graham Upside | n/a | 
Stock Splits
 The last stock split was on June 2, 2025. It was a reverse split with a ratio of 1:20.
 | Last Split Date | Jun 2, 2025 | 
| Split Type | Reverse | 
| Split Ratio | 1:20 | 
Scores
 LYEL has an Altman Z-Score of -4.6 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
 | Altman Z-Score | -4.6 | 
| Piotroski F-Score | 1 |